Currently available drugs are unable to repair the nerve damage caused by stroke.[5–7] Presently, the treatment of ischemic stroke is limited to thrombectomy and the administration of tissue plasminogen activator (tPA),[8] but these 2 methods have a narrow time window in which they are effective. The gene discussed is PLAT; the disease is ischemic stroke.